MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1567205014666171110160556

Медицинская библиотека · Current Alzheimer research · 2018

Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia.

Lauriola Michele, Paroni Giulia, Ciccone Filomena, D Onofrio Grazia, Cascavilla Leandro, Paris Francesco, Gravina Carolina, Urbano Maria, Seripa Davide, Greco Antonio

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Although it is known that Alzheimer's disease (AD) is associated with the progressive accumulation of amyloid β-peptide (Aβ) in the human brain, its pathogenic role has to be completely clarified. Aβ moves from the bloodbrain barrier to the plasma and an increased Aβ production in brain could be associated with higher Aβ concentrations in blood. A recent study has evaluated Aβ40 and Aβ42 levels in human red blood cells (RBCs) with evidence of agedependent higher Aβ concentration in RBCs.

OBJECTIVE

The aim of the study was to investigate if erythrocyte associated Aβ (iAβ) levels could be different in subjects affected by dementia in comparison with controls and according to the patient's cognitive impairment or different dementia subtypes.

METHOD: To answer these questions we assessed iAβ40 and iAβ42 levels in 116 patients: 32 healthy controls, 39 with diagnosis of vascular dementia (VaD), 14 mild cognitive impairment (MCI) and 31 AD.

RESULTS

In this population we found significant differences in iAβ42 between controls and cognitive impaired patients. Moreover, iAβ42 significantly differed between dementia vs MCI. AD also showed different iAβ42 levels as compared to VaD. Conversely, no differences were found for iAβ40. All the analyses were adjusted for potential confounders like age, gender and Hb concentration. A direct correlation between increasing iAβ42 concentration and the progression of the cognitive decline using the MMSE score as continuous variable was also found.

CONCLUSION

Our findings support the evidence that iAβ42 could be an instrument to early recognize dementia and predict cognitive impairment.

Для цитирования: Lauriola Michele, Paroni Giulia, Ciccone Filomena, D Onofrio Grazia, Cascavilla Leandro, Paris Francesco, Gravina Carolina, Urbano Maria, Seripa Davide, Greco Antonio. Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia.. Current Alzheimer research. 2018. DOI: 10.2174/1567205014666171110160556.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.